Whether it's a man or woman who writes an external letter for a faculty member’s promotion is linked to both the contents of ...

Mr. Wickham recently spoke with Becker's about CommonSpirit's journey to build a standardized, data-driven approach to ED efficiency, the insights gained from tracking performance at scale and the ...

Hims and other telehealth companies make finasteride easy to get and don’t have to disclose side effects in ads.

Health systems should ground their tech expectations in clear use cases and collaborative education, leaders shared at the ...

Roller-coaster healthcare stock Hims & Hers Health ( HIMS -1.34%), whose stock got devastated last week by worries that it ...

Four-star-rated analyst Daniel Grosslight at Citi reiterated his Sell rating on Hims & Hers Health (HIMS) stock yesterday, ...

Bristol Myers Squibb said it will acquire its struggling CAR-T partner 2Seventy Bio for $286 million, or $102 million net of ...

Would you like to be notified of the latest news and updates on the stock market?

Read on for our full review and how to decide ... and generic medications for common ED treatments, like sildenafil (Viagra) and tadalafil (Cialis). Hims has also created a partner brand, Hers ...

Whether you played a sport in high school, college or even at the professional level, chances are you heard someone in a locker room talking about intimacy before the big game. But is this just ...

Many treatments are available, and with the popularity of online and mail-order services in recent years, two leaders are BlueChew and Hims. Both companies offer different ED treatments and a ...

The move: Hims & Hers stock plunged by as much as 27% on Tuesday, hitting an intraday low of $37.29. The stock is down by 49% from its peak of $72.98 last week. The chart: Why: Hims & Hers said it ...